Your browser does not support JavaScript!

Tide Technology History

  • 1999
  • 2002
  • 2004
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2015
  • 2016
  • 2017
  • August 2019
  • December 2019
  • December 2019
  • 2020
  • Development of the single-use TideCell® prototype and complementary products in ITRI Biomedical Technology  and Device Research Laboratories, Taiwan.
    TideCell® is the second single-use bioreactor developed in the world (after the 1998 Wave system). 

     

    Patented the regions’ first single use bioprocessing bioreactor Tide Motion (2nd globally after wave in 1998) started providing PD services.

    Launched BioNOC macrocarrierBioNOC is the first macroporous carrier in the world that uses only one type of material.


    Launched the single-use CelCradle system. CelCradle is the first high density single-use laboratory scale cell culture system.  One CelCradle bottle can replace up to  20 roller bottles.

    Launched the BioNOC™ II macrocarriers.

    Launched the GlucCell® glucose meter. GlucCell® is the first palm-sized portable glucose meter made specifically for cell culture process monitoring in the world


    Launched and installed the single-use TideCell® 10L system in China vaccine company. It is used for hog cholera vaccine production.
    TideCell® is the first single-use high density cell culture system introduced in the Chinese market

    Launched and installed single-use TideCell® 100L system in China vaccine company. It is used for rabies vaccine production.

    Launched the TideCell® 20L system

    Launched the TideCell® 2L system

    Successfully installed TideCell® 100L system in India for rabies vaccine  production

    Launched the TideCell® Cell Harvest System and AutoSwitch System.

    Successfully installed TideCell® 100L system in Japan for Hepatitis vaccine production.

    This is the first case that demonstrated the linear scale-up capability of the Tide motion system


    Tide technology is continually being developed and is being marketed under the Esco Healthcare division VacciXcell



    Launched VXLHybrid Bioreactor.


    Launched the new and improved TideCell® in the US. The enhancements included addition of standard hypoxic condition, compressed air path with double HEPA and VOC filter, and germicidal UV-C decontamination. Another addition included the PLC-based monitoring and control system.



    Launched TideXcell™ bioreactor for cGMP compliant adherent cell culture scale up.


    CelCradle™ X, a single use, closed and automated bioreactor, was launched for small-scale process development and GMP-compliant clinical applications. 

     

    Launching of CelXrocker™, a proof of concept bioreactor for adherent cell culture, as a new addition to the Tide Motion bioreactor family


    Launching of CelShaker™ a new addition to the cell harvesting application of the Tide Motion technology. CelShaker™ is an automated cell harvester for the CelCradle™ system.



    Stay Updated!

    Sign up to our newsletter and receive the latest news and updates about our products!

    Lab Image